Kilbourn, R G <br/><br/>
NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs.  [electronic resource] 

 -  Critical care medicine  Nov 1994 
 - 1835-40 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0090-3493 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Arginine--administration & dosage<br/>Cardiovascular System--drug effects<br/>Dobutamine--administration & dosage<br/>Dogs<br/>Dose-Response Relationship, Drug<br/>Drug Evaluation, Preclinical<br/>Drug Synergism<br/>Drug Therapy, Combination<br/>Male<br/>Nitric Oxide--antagonists & inhibitors<br/>Prospective Studies<br/>Random Allocation<br/>Shock, Septic--drug therapy<br/>Time Factors<br/>omega-N-Methylarginine